Showing results (581-590 of 640) with videos related to

Sort By:
Pageof 64
Urology|August 1, 1995
Goserelin versus orchiectomy in the treatment of advanced prostate cancer: final results of a randomized trial. Zoladex Prostate Study GroupN J Vogelzang, G W Chodak, M S Soloway, et al.
World Journal of Urology|June 22, 2011
Pathologic evaluation of non-neoplastic renal parenchyma in partial nephrectomy specimensMichael Garcia-Roig, Michael A Gorin, Carlos Parra-Herran, et al.
Cancer Treatment Reports|February 1, 1980
Phase I-II study of mitomycin C topical therapy for low-grade, low stage transitional cell carcinoma of the bladder: an interim reportM D DeFuria, R B Bracken, D E Johnson, et al.
The Journal of Urology|September 21, 2010
Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancerArnulf Stenzl, Maximilian Burger, Yves Fradet, et al.
The New England Journal of Medicine|April 2, 1981
Identification of patients with cholesterol or pigment gallstones by discriminant analysis of radiographic featuresS M Dolgin, J S Schwartz, H Y Kressel, et al.
Urology|January 11, 1991
Zoladex versus orchiectomy in treatment of advanced prostate cancer: a randomized trial. Zoladex Prostate Study GroupM S Soloway, G Chodak, N J Vogelzang, et al.
BJU International|June 15, 1999
Endocrine effects, efficacy and tolerability of a 10.8-mg depot formulation of goserelin acetate administered every 13 weeks to patients with advanced prostate cancerM F Sarosdy, P F Schellhammer, M S Soloway, et al.
Southern Medical Journal|November 1, 1983
Use of tumor colony assay in clinical oncologyH B Niell, C L Neely, C A Wood, et al.
JAMA|August 21, 1987
Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgeryW U Shipley, G R Prout, A B Einstein, et al.
Der Urologe. Ausg. A|April 24, 2001
[Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers]S H Hautmann, G L Schroeder, F Civantos, et al.
Pageof 64